EM Imaging Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

EM Imaging General Information

Description

Developer of a molecular targeting technology designed to create a disease-focused approach to optical tracer and therapeutic compound development. The company's technology creates small molecules and peptides that, when conjugated with radionuclides or fluorescent dyes, target specifically cancerous cells and other diseased tissues, enabling healthcare professionals to detect and treat diseases in real-time during interventional procedures, including surgery and provide accurate treatment while sparing healthy tissue.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 9 Little France Road
  • Edinburgh BioQuarter (Gate 3)
  • Edinburgh EH16 4UX
  • Scotland, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 9 Little France Road
  • Edinburgh BioQuarter (Gate 3)
  • Edinburgh EH16 4UX
  • Scotland, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EM Imaging Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Out of Business 26-Aug-2025 Completed Out of Business
12. Secondary Transaction - Private Completed Clinical Trials - Phase 2
11. Later Stage VC 07-Nov-2019 Completed Clinical Trials - Phase 2
10. Early Stage VC (Series A) 21-May-2018 Completed Clinical Trials - Phase 1
9. Grant 01-Dec-2017 Completed Clinical Trials - Phase 1
8. Early Stage VC 26-May-2017 Completed Clinical Trials - Phase 1
7. Early Stage VC (Series A) 25-Jul-2016 Completed Clinical Trials - Phase 1
6. Early Stage VC (Series A) 01-Apr-2016 Completed Clinical Trials - Phase 1
5. Grant 01-Mar-2016 $214K $9.4M Completed Clinical Trials - Phase 1
4. Grant 15-Dec-2015 $50.5K $9.4M Completed Clinical Trials - Phase 1
To view EM Imaging’s complete valuation and funding history, request access »

EM Imaging Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Preferred
To view EM Imaging’s complete cap table history, request access »

EM Imaging Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular targeting technology designed to create a disease-focused approach to optical tracer and therap
Drug Discovery
Edinburgh, United Kingdom
7 As of 2024

Oxford, United Kingdom
 

Montpellier, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EM Imaging Competitors (7)

One of EM Imaging’s 7 competitors is Blue Earth Diagnostics, a Formerly VC-backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Blue Earth Diagnostics Formerly VC-backed Oxford, United Kingdom
SurgiMab Venture Capital-Backed Montpellier, France
Fusion Pharmaceuticals Formerly VC-backed Hamilton, Canada
Advanced Accelerator Applications Formerly VC-backed Rueil-Malmaison, France
On Target Laboratories Venture Capital-Backed West Lafayette, IN
You’re viewing 5 of 7 competitors. Get the full list »

EM Imaging Patents

EM Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202315697-D0 Compounds and methods of use Inactive 13-Oct-2023
GB-202212937-D0 Compounds and methods of use Inactive 05-Sep-2022
GB-202004360-D0 Compounds and methods of use Inactive 26-Mar-2020
CA-3142866-A1 Compound comprising a cmet binding cyclic peptide for human or animal administration and uses thereof Pending 14-Jun-2019
AU-2020291197-A1 Compounds and methods of use Active 14-Jun-2019 A61K51/088
To view EM Imaging’s complete patent history, request access »

EM Imaging Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EM Imaging Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The University of Edinburgh University
To view EM Imaging’s complete investors history, request access »

EM Imaging FAQs

  • When was EM Imaging founded?

    EM Imaging was founded in 2014.

  • Where is EM Imaging headquartered?

    EM Imaging is headquartered in Edinburgh, United Kingdom.

  • What is the size of EM Imaging?

    EM Imaging has 7 total employees.

  • What industry is EM Imaging in?

    EM Imaging’s primary industry is Drug Discovery.

  • Is EM Imaging a private or public company?

    EM Imaging is a Private company.

  • What is EM Imaging’s current revenue?

    The current revenue for EM Imaging is .

  • How much funding has EM Imaging raised over time?

    EM Imaging has raised $22M.

  • Who are EM Imaging’s investors?

    The University of Edinburgh has invested in EM Imaging.

  • Who are EM Imaging’s competitors?

    Blue Earth Diagnostics, SurgiMab, Fusion Pharmaceuticals, Advanced Accelerator Applications, and On Target Laboratories are some of the 7 competitors of EM Imaging.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process